STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

STERIS plc (STE) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, STERIS plc (STE) trades at a P/E ratio of 27.1×. Over the past ten years it has ranged from 0.0× (March 2023) to 203× (June 2023); the current reading is higher than 7% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 27.8× (23.64%)
FY2025 36.4× (36.96%)
FY2024 57.7× (67.11%)
FY2023 175× 75.65%
FY2022 99.9× 143.36%
FY2021 41.1× 41.07%
FY2020 29.1× (17.56%)
FY2019 35.3× 33.02%
FY2018 26.5× (51.10%)
FY2017 54.3× 13.80%

Quarterly newest first

Period P/E ratio Change
Jun 2026 25.6× (7.68%)
Mar 2026 27.8× (21.21%)
Dec 2025 35.3× (0.39%)
Sep 2025 35.4× (3.33%)
42 more quarters

Against its own ten years

Low 0.0× High 203×
Ten-year median 38.2×
Current reading's percentile 4

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on STE